Fri07252014

Last update 09:48:53 AM EST

HIV Diagnosis Rate Down More than 30 Percent in the US

HIV Diagnosis Rate Down More than 30 Percent in the US

Researchers recently reported that the annual ra...

Diplomat Acquires MedPro Rx

Diplomat Acquires MedPro Rx

Flint-based Diplomat recently announced that i...

FDA Approves Salix's Hereditary Angioedema Drug

FDA Approves Salix's Hereditary Angioedema Drug

On Thursday, Salix Pharmaceuticals, Ltd. and p...

FDA Approves Salix's Hereditary Angioedema Drug

FDA Approves Salix's Hereditary Angioedema Drug

On Thursday, Salix Pharmaceuticals, Ltd. and partner Pharming Group NV annou...

Regulus Therapeutics' Rare Kidney Disease Therapy Receives Orphan Drug Designation from the FDA

Regulus Therapeutics' Rare Kidney Disease Therapy Receives Orphan Drug Designation from the FDA

The US Food and Drug Administration (FDA) granted orphan drug designation to...

HIV Diagnosis Rate Down More than 30 Percent in the US

HIV Diagnosis Rate Down More than 30 Percent in the US

Researchers recently reported that the annual rate for diagnosis for HIV infec...

FDA Approves Strides' Transplant Drug

FDA Approves Strides' Transplant Drug

Today, Strides Arcolab announced that the US Food and Drug Administration (F...

FDA Approves Gilead's Zydelig for Three Types of Blood Cancers

FDA Approves Gilead's Zydelig for Three Types of Blood Cancers

Gilead Sciences, Inc. announced that the US Food and Drug Administration (FD...

Puma Shares Triple on Positive Late-Stage Results of its Breast Cancer Drug

Puma Shares Triple on Positive Late-Stage Results of its Breast Cancer Drug

On Tuesday, Puma Biotechnology, Inc. announced that its experimental breast ...

AstraZeneca's MedImmune Partners with Advaxis for Cancer Immunotherapy

AstraZeneca's MedImmune Partners with Advaxis for Cancer Immunotherapy

AstraZeneca recently announced that its biologics research and development a...

FDA Grants Priority Review for Genentech's Avastin in Platinum-Resistant Ovarian Cancer

FDA Grants Priority Review for Genentech's Avastin in Platinum-Resistant Ovarian Cancer

On Tuesday, Genentech, a member of the Roche Group, announced that its suppl...

Researchers Identify Potential Target for Immunotherapy in Patients with Early-Stage Breast Cancer

Researchers Identify Potential Target for Immunotherapy in Patients with Early-Stage Breast Cancer

Researchers from the Yale Cancer Center utilized a novel molecular analysis to...

Study Finds Negative HPV Screening Test Serves as a Better Predictor of Lower Cervical Cancer Risk than a Negative Pap Test

Study Finds Negative HPV Screening Test Serves as a Better Predictor of Lower Cervical Cancer Risk than a Negative Pap Test

A negative test for human papillomavirus (HPV) infection provides greater as...

FDA Grants Breakthrough Therapy Designation to Aduro's Pancreatic Cancer Combo Therapy

FDA Grants Breakthrough Therapy Designation to Aduro's Pancreatic Cancer Combo Therapy

Today, Aduro BioTech, Inc. announced that its pancreatic cancer combination ...

Committee Recommends GlaxoSmithKline's Melanoma Study Be Stopped Early due to Favorable Survival Results

Committee Recommends GlaxoSmithKline's Melanoma Study Be Stopped Early due to Favorable Survival Results

An Independent Data Monitoring Committee (IDMC) has recommended GlaxoSmithKl...

Diplomat Acquires MedPro Rx

Diplomat Acquires MedPro Rx

Flint-based Diplomat recently announced that it has acquired Raleigh-based M...

Pfizer to Acquire InnoPharma, Boosting its Injectables Business

Pfizer to Acquire InnoPharma, Boosting its Injectables Business

Pfizer Inc. recently announced that it has entered into an agreement to acquir...

Shire Agrees to Latest Takeover Bid from AbbVie

Shire Agrees to Latest Takeover Bid from AbbVie

US-based AbbVie has entered into a deal to acquire Dublin-based Shire for $5...